openPR Logo
Press release

Neurological Disorder Diagnostics Market Technology Research and Global Outlook 2021 to 2028 | Siemens Healthineers, Koninklijke Philips N.V., General Electric Company

10-22-2021 09:23 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Neurological Disorder Diagnostics Market

Neurological Disorder Diagnostics Market

Neurological Disorder Diagnostics Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the Neurological Disorder Diagnostics Industry.

Neurological Disorder Diagnostics Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective business decisions. One of the objectives of this report is to identify the latest developments, market shares, and strategies employed by the major market players. Besides, the least competitive market niches with significant growth potential are also identified. For research methodology, secondary research, primary research, subject matter expert advice, quality check, and final review was utilized.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1867

Neurological disorder diagnostics tools are medical devices that are used for diagnosing various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices, which are majorly used in diagnosis include imaging tools such as computed tomography (CT), magnetic resonance imaging (MRI), and in vitro diagnostic tools such as biomarkers and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic tools. For instance, according to data published by Alzheimer’s Association in 2018, around 5.7 million people in the U.S. of all age groups suffered from Alzheimer’s and dementia in 2017.

Furthermore, various private and government organizations are taking initiatives to raise awareness about neurological disorders by providing knowledge of diagnosis and treatment about neurological disorders, which is expected to drive the market growth. For instance, in 2012, Georgetown University Medical Center in collaboration with MedStar Georgetown University Hospital, established Huntington Disease Care, Education, and Research Center that offers diagnosis, treatment, and patient education for Huntington’s disease.

The global neurological disorder diagnostics market size is expected to be valued at US$ 12,162.6 million in 2019 and is expected to exhibit a CAGR of 7.6% over the forecast period (2019–2027).

Increasing number of approvals and launches of novel diagnostic tools

In the recent past, several key players in the market have received approval for launching novel diagnostic tools. Moreover, approval and launch of such novel tools in the market is expected to create lucrative environment for the global neurological disorder diagnostics market growth over the forecast period. For instance, in April 2018, Canon Medical Systems received 510 (k) clearance from the U.S. Food and Drug Administration for its new Aquilion Precision (CT) scanner. Aquilion Precision is an ultra-high resolution CT system (UHR CT).

Moreover, in March 2018, Koninklijke Philips N.V. launched its new 3-tesla MRI scanner, Elition 3.0T. This new MRI scanner reduces scanning time by 50%, which is expected to enhance patient experience. Furthermore, in January 2019, Canon Medical Systems Corporation launched Aquilion Start CT system with 16 and 32 slice configurations suitable for institutions aspiring to make diagnostic CT imaging more accessible and affordable.

However, high cost of diagnostic tools such as MRI machines and CT scan is a major factor, which is expected to hinder growth of global neurological disorder diagnostics market in emerging economies such as India, and China. According to American Health Imaging, price of a magnetic resonance imaging (MRI) devices starts from US$ 150,000, and a high end device costs more than US$ 1 million. Such high cost devices are only adopted by big hospitals and diagnostic laboratories.

Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth

Strategic collaborations among key players are expected to fuel growth of the global neurological disorder diagnosis market over the forecast period. For instance, in March 2018, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into a collaborative research for the development of deep learning technology in magnetic resonance imaging.

Purchase this Premium Report With Discount – https://www.coherentmarketinsights.com/promo/buynow/1867

Major Players Are Operating In This Market Are: Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation

Highlights of the Neurological Disorder Diagnostics report:

1. A complete backdrop analysis, which includes an assessment of the Neurological Disorder Diagnostics Market
2. An objective assessment of the trajectory of the market
3. Market segmentation up to the second or third level
4. Reporting and evaluation of recent industry developments
5. Important changes in market dynamics
6. Emerging niche segments and regional markets
7. Historical, current, and projected size of the market from the standpoint of both value and volume
8. Market shares and strategies of key players
9. Recommendations to companies for strengthening their foothold in the market

To conclude, the Neurological Disorder Diagnostics Market report mentions the key geographies, market landscapes alongside the production and consumption analysis, supply and demand analysis, market growth rate, along with future forecast etc. This report also provides SWOT and PEST analysis, investment feasibility and return analysis. Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Disorder Diagnostics Market Technology Research and Global Outlook 2021 to 2028 | Siemens Healthineers, Koninklijke Philips N.V., General Electric Company here

News-ID: 2437678 • Views:

More Releases from Coherent Market Insights

Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Flavored Syrups Market Is Booming So Rapidly Growth by 2032| Starbucks, Fontana, Amoretti, Jordan's Skinny Syrups
Flavored Syrups Market Is Booming So Rapidly Growth by 2032| Starbucks, Fontana, …
The latest study by Coherent Market Insights, titled "Flavored Syrups Market Size, Share & Trends Forecast 2025-2032," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2025 and 2032. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants
Gourmet Salts Market Booming with Rapid Growth Through 2032: Himalayan Chef, Morton Salt, Cargill, Diamond Crystal
Gourmet Salts Market Booming with Rapid Growth Through 2032: Himalayan Chef, Mor …
The latest study by Coherent Market Insights, titled "Gourmet Salts Market Size, Share & Trends Forecast 2025-2032," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2025 and 2032. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants

All 5 Releases


More Releases for Neurological

Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth
Neurological Biomarkers Market : An Overview
Introduction: Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for
Neurological Biomarkers Market: An Overview
Introduction: Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of